EP1429782A4 - Modulation of vitamin storage - Google Patents
Modulation of vitamin storageInfo
- Publication number
- EP1429782A4 EP1429782A4 EP02799356A EP02799356A EP1429782A4 EP 1429782 A4 EP1429782 A4 EP 1429782A4 EP 02799356 A EP02799356 A EP 02799356A EP 02799356 A EP02799356 A EP 02799356A EP 1429782 A4 EP1429782 A4 EP 1429782A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- modulation
- vitamin storage
- vitamin
- storage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOPCT/AU01/01206 | 2001-09-26 | ||
PCT/AU2001/001206 WO2002026238A1 (en) | 2000-09-26 | 2001-09-26 | Phosphate derivative supplements |
AU2002951045A AU2002951045A0 (en) | 2002-08-27 | 2002-08-27 | Method of supplementing nascent endogenous storage forms |
AU2002951045 | 2002-08-27 | ||
PCT/AU2002/001321 WO2003026673A1 (en) | 2001-09-26 | 2002-09-26 | Modulation of vitamin storage |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1429782A1 EP1429782A1 (en) | 2004-06-23 |
EP1429782A4 true EP1429782A4 (en) | 2005-02-02 |
Family
ID=25613914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02799356A Ceased EP1429782A4 (en) | 2001-09-26 | 2002-09-26 | Modulation of vitamin storage |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1429782A4 (en) |
JP (1) | JP2005515969A (en) |
CA (1) | CA2458279A1 (en) |
MX (1) | MXPA04001779A (en) |
WO (1) | WO2003026673A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
KR20050086954A (en) * | 2003-01-17 | 2005-08-30 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | Compounds having anti-proliferative properties |
BRPI0508125A (en) * | 2004-03-03 | 2007-07-17 | Vital Health Sciences Pty Ltd | alkaloid formulation, method for improving the effectiveness of an alkaloid, use of the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents, together with excipients and pharmaceutical composition |
BRPI0513673B8 (en) * | 2004-08-03 | 2021-07-27 | Vital Health Sciences Pty Ltd | method for producing a drug to increase the efficacy and transport of enterally administered biologically active compounds, and pharmaceutical composition |
EP1861091B1 (en) * | 2005-03-03 | 2013-12-11 | Vital Health Sciences Pty Ltd. | Compounds having lipid lowering properties |
JP2008531602A (en) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | Compounds with anticancer properties |
CA2611831C (en) | 2005-06-17 | 2014-09-16 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
EP2531047A4 (en) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | Carrier comprising non-neutralised tocopheryl phosphate |
KR20120115991A (en) * | 2010-02-05 | 2012-10-19 | 포스파제닉스 리미티드 | Carrier composition |
MX2012011355A (en) | 2010-03-30 | 2012-11-30 | Phosphagenics Ltd | Transdermal delivery patch. |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
CA3007587C (en) | 2015-12-09 | 2023-12-05 | Phosphagenics Limited | Pharmaceutical formulation |
JP7198754B2 (en) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | Method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0430045A2 (en) * | 1989-11-21 | 1991-06-05 | Senju Pharmaceutical Co., Ltd. | Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction |
US5607921A (en) * | 1994-01-31 | 1997-03-04 | L'oreal | Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
US5776915A (en) * | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
JPH1143436A (en) * | 1997-07-25 | 1999-02-16 | Showa Denko Kk | Medicine for preventing/treating periphery blood stream disorder |
JPH11199424A (en) * | 1997-12-26 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114957A (en) * | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
US5643597A (en) * | 1991-08-01 | 1997-07-01 | Lvmh Recherche | Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
FR2679904A1 (en) * | 1991-08-01 | 1993-02-05 | Lvmh Rech | Use of a tocopherol phosphate, or of one of its derivatives, in the preparation of cosmetic or pharmaceutical compositions and compositions thus obtained |
WO1993015731A1 (en) * | 1992-02-14 | 1993-08-19 | Robert Lamb | Phosphate derivatives of vitamin e to protect cells from effects of aging and injury |
JPH05286848A (en) * | 1992-04-10 | 1993-11-02 | Senju Pharmaceut Co Ltd | Bathing agent |
JP3362501B2 (en) * | 1994-04-28 | 2003-01-07 | 千寿製薬株式会社 | Corneal disorder treatment |
JPH10155429A (en) * | 1996-11-27 | 1998-06-16 | Showa Denko Kk | Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition |
WO2002026238A1 (en) * | 2000-09-26 | 2002-04-04 | Vital Health Sciences Pty Ltd. | Phosphate derivative supplements |
-
2002
- 2002-09-26 MX MXPA04001779A patent/MXPA04001779A/en unknown
- 2002-09-26 JP JP2003530308A patent/JP2005515969A/en active Pending
- 2002-09-26 CA CA002458279A patent/CA2458279A1/en not_active Abandoned
- 2002-09-26 EP EP02799356A patent/EP1429782A4/en not_active Ceased
- 2002-09-26 WO PCT/AU2002/001321 patent/WO2003026673A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0430045A2 (en) * | 1989-11-21 | 1991-06-05 | Senju Pharmaceutical Co., Ltd. | Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction |
US5607921A (en) * | 1994-01-31 | 1997-03-04 | L'oreal | Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
JPH1143436A (en) * | 1997-07-25 | 1999-02-16 | Showa Denko Kk | Medicine for preventing/treating periphery blood stream disorder |
US5776915A (en) * | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
JPH11199424A (en) * | 1997-12-26 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
Non-Patent Citations (3)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 05 31 May 1999 (1999-05-31) * |
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12 29 October 1999 (1999-10-29) * |
See also references of WO03026673A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1429782A1 (en) | 2004-06-23 |
MXPA04001779A (en) | 2004-05-31 |
WO2003026673A1 (en) | 2003-04-03 |
JP2005515969A (en) | 2005-06-02 |
CA2458279A1 (en) | 2003-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002255329A1 (en) | Stable solution of reduced coenzyme Q | |
HK1067907A1 (en) | Amplifier modulation | |
TW487177U (en) | Anti-dust lid of connecting slot | |
HUP0401534A3 (en) | Modified factor ix | |
AU2002244203A1 (en) | Devices and methods for prolonging the storage life of produce | |
TW509023U (en) | Cosmetic case | |
EP1429782A4 (en) | Modulation of vitamin storage | |
AU2003252072A8 (en) | Modulation of protein kinase c-iota expression | |
AU2002366788A1 (en) | Antisense modulation of ship-1 expression | |
AU2002318139A1 (en) | Antisense modulation of src-c expression | |
GB0126781D0 (en) | Modulation | |
GB0124321D0 (en) | Modulation determination | |
AU2002357102A1 (en) | Antisense modulation of cd36l1 expression | |
AU2003257966A1 (en) | Antisense modulation of lar expression | |
IL162747A0 (en) | Modulation of heat-shock-protein-based immunotherapies | |
AU2003295790A8 (en) | Modulation of iap-like expression | |
AU2002322551A1 (en) | Antisense modulation of rip2 expression | |
AU2002347809A1 (en) | Antisense modulation of inhibitor-kappa b kinase-gamma expression | |
AU2003290763A8 (en) | Modulation of jumonji expression | |
GB0106857D0 (en) | Storage | |
AU2002329838A1 (en) | Modulation of appl expression | |
AU2002244086A1 (en) | Antisense modulation of recql4 expression | |
WO2003048376A9 (en) | Modulation of immune-cell related disorders using il-1hy2 | |
AU2002353153A8 (en) | Antisense modulation of tfap2c expression | |
AU2002362942A1 (en) | Modulation of tor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040323 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041221 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20070708 |